By Eleanor Whitfield
Former buy-side analyst. Leads the desk with a focus on global markets, macro flows and what moves portfolios.
Unilever Surge Lifts European Consumer Stocks as Barclays Slips
European stocks inched up Tuesday, powered by consumer staples like Unilever, which jumped nearly 9% after reporting 5.8% underlying sales g
Coca-Cola loses India market share as Diet Coke demand surges 10x
Coca-Cola lost market share in India in the second quarter, hurt by a lack of mid-priced pack sizes and rising aluminum costs. Meanwhile, Di
Elevance Health insiders buy shares as CEO and chair add to holdings
Elevance Health CEO Gail Boudreaux bought $1 million of stock on July 17, and chair Ramiro Peru made his first purchase since 2008. Insider
GMEX Robotics acquires 30% stake in Alpha Meta AI with revenue-linked earnout
GMEX Robotics has agreed to acquire a 30% stake in Alpha Meta AI, a Singapore-based firm behind MediaMeta and MetaGen AI. The deal combines
Baltic Dry Index Slips to Two-Week Low as Freight Rates Cool Across All Vessel Sizes
The Baltic Dry Index dropped 1.2% to 2,664 on Tuesday, its lowest level since July 2, as freight rates for capesize, panamax, and supramax v
Why Wall Street isn't rattled by 30-year Treasury yields above 5%
The 30-year US Treasury yield has topped 5% for the first time in nearly two decades, yet major stock indexes are hovering near all-time hig
Incyte raises 2026 outlook after Opzelura Medicaid rebate deal
Incyte raised its 2026 revenue outlook after a June deal with CMS altered Medicaid rebate calculations for its eczema drug Opzelura. The cha
Apple launches device leasing in US with Klarna, starting at $17.99 a month
Apple has introduced a device leasing program in the US with Klarna, allowing customers to pay monthly for iPhones, Macs, iPads, and Apple W
Dow and Nasdaq split as Trump hints at Iran deal while chip stocks slide
Dow futures rose on hopes of a diplomatic breakthrough with Iran, but Nasdaq futures fell as chip stocks continued their recent slide. Oil p
GSK slashes £1.9 billion in costs to fuel drug pipeline and chase £40 billion revenue goal
GSK has announced a £1.9 billion cost-cutting plan over three years. The savings will fund late-stage drug development as the company aims f
Indian IT stocks jump 3.3% as Nifty holds steady ahead of Fed rate decision
A 3.3% jump in IT shares helped India's Nifty 50 stay nearly flat on Tuesday, even as most sectors fell. Investors were focused on the Feder
Castellum's asset sales outpace plan but leave riskier portfolio, analyst warns
Analysts at AlphaValue/Baader Europe lifted their price target on Swedish property firm Castellum to 125 kronor but maintained a reduce rati